Skip to content

Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment

Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment: a Prospective Monocenter Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04732312
Acronym
PIAF-QVA
Enrollment
12
Registered
2021-02-01
Start date
2019-03-19
Completion date
2019-10-16
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Cognitive Decline

Keywords

cognitive impairment, caregiver quality of life, caregiver burden, caregiver vulnerability

Brief summary

The purpose of this prospective monocenter observational study is to assess the impact of the first introduction of formal home help (personalized autonomy allowance for seniors) on the quality of life of home caregivers of elderly patients with neurocognitive impairment.

Detailed description

An aging population is leading to an increase in neurodegenerative disorders that are responsible for loss of autonomy. In order to keep patients with neurocognitive impairment at home, the availability of home caregivers is essential. The neurocognitive deterioration of elderly patients is a significant burden for home caregivers and can affect their quality of life. The implementation of formal home help (personalized autonomy allowance for seniors) can relieve home caregivers and improve their quality of life. Conduct of research: Elderly patients followed in the geriatric department of the Mulhouse French hospital, and for whom a formal home help (personalized autonomy allowance for seniors) is initiated will be recruited. The evolution of home caregiver's quality of life, burden and vulnerability, will be assessed during three months.

Interventions

OTHERHome help

Setting up of a formal home help

Sponsors

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient 60 years of age or older * Diagnosis of neurocognitive disorders * MMSE score less than or equal to 26 * GIR score inferior or equal to 4 * Introduction of formal home help (personalized autonomy allowance for seniors program) * Patient living in Haut-Rhin department (France) * Patient receiving regular informal help at home (at least once a week) * Availability of the current home helper to participate in the sudy * Non-opposition to participation in the study

Exclusion criteria

* Introduction of formal home care not related to the personalized autonomy allowance program * Patient under legal protection

Design outcomes

Primary

MeasureTime frameDescription
Caregiver quality of life90 daysVariation of caregiver quality of life between inclusion and 90 days. Quality of life is assessed with the PIXEL study evaluation scale. This is a 20-item scale, subdivided in four domains: behavioral capacities to face difficulties generated by the patient, relation with the environment, psychological perception of the situation, perception of a possible distress. Score ranges from 0 to 100 points (5 points for each item).

Secondary

MeasureTime frameDescription
Caregiver burden90 daysVariation of caregiver burden between inclusion and 90 days. Burden is assessed with the 7-item mini-Zarit scale. Score ranges from 0 to 7.
Caregiver quality of life according to the type of formal home care90 daysVariation of caregiver quality of life between inclusion and 90 days. Quality of life is assessed with the PIXEL study evaluation scale.
Caregiver vulnerability according to the type of formal home care90 daysVulnerability is assessed through another PIXEL study 20-item evaluation scale.
Caregiver vulnerability90 daysVariation of caregiver vulnerability between inclusion and 90 days. Vulnerability is assessed through another PIXEL study 20-item evaluation scale. Score ranges from 0 to 100 points.
Variation of quality of life score according to each domain90 daysEvolution of quality of life according to each domain of the PIXEL study evaluation scale.
Description of the aids set up within the framework of the personalized autonomy allowance for seniors program.90 daysFormal home help can include several home services: meal delivery, domestic help, home care nurse, etc.
Caregiver burden according to the type of formal home care90 daysVariation of caregiver burden between inclusion and 90 days. Burden is assessed with the 7-item mini-Zarit scale. Score ranges from 0 to 7.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026